ASTRAZENECA
AstraZeneca is global innovation-driven biopharmaceutical company specialising in the discovery, development, manufacturing and marketing of prescription medicines that make a meaningful difference in healthcare. AstraZeneca discovers new medicines that are designed to improve the health and quality of life of patients around the world - medicines which are innovative, effective and which offer added benefits such as reduced side effects or better ways of taking the treatment. They also focus on getting the best from every medicine they make by exploring all the ways it can be used or improved. Their business strategy sets out their path to success in delivering great medicines to patients through innovative science and global excellence in development and commercialisation.
ASTRAZENECA
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
1999-04-06
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.astrazeneca.com
Total Employee:
10001+
Status:
Active
Contact:
+44 20 3749 5000
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon Google Tag Manager Font Awesome Domain Not Resolving Apache Mobile Non Scaleable Content Euro
Similar Organizations
AbbVie
AbbVie is a pharmaceutical company that discovers, develops, and markets both biopharmaceuticals and small molecule drugs.
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals is a biopharmaceutical company focused on the discovery, development and commercialization.
AVEO Oncology
AVEO is a biopharmaceutical company that offers drug development strategies for targeted cancer therapeutics.
BioDelivery Sciences
BioDelivery Sciences is a pharmaceutical company that focuses on pain management and addiction medicine.
Eli Lilly
Eli Lilly engages in the discovery, development, manufacture, and sale of products in pharmaceutical products business segment.
Fagron SA
Fagron is a pharmaceutical company specializing in chemicals, equipment, and supplies solutions.
FORMA Therapeutics
FORMA Therapeutics is a biopharmaceutical company focused on the discovery, development, and commercialization of transformative medicines.
Gilead Sciences
Gilead Sciences is a biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases.
Novartis
Novartis is a healthcare company that provides solutions to address the evolving needs of patients worldwide.
Novo Nordisk
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
SHANDONG KEXING BIOPRODUCTS CO LTD
Kexing Pharmaceutical is a cutting-edge biopharma company that develops, manufactures, and distributes recombinant protein medications.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Theravance Biopharma
Theravance Biopharma is a biopharmaceutical company with one approved product.
Current Advisors List
Current Employees Featured
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-05 | TeneoTwo | TeneoTwo acquired by AstraZeneca | 100 M USD |
| 2021-09-29 | Caelum Biosciences | Caelum Biosciences acquired by AstraZeneca | 500 M USD |
| 2020-12-12 | Alexion Pharmaceuticals | Alexion Pharmaceuticals acquired by AstraZeneca | 39 B USD |
| 2016-04-16 | Takeda Respiratory Business | Takeda Respiratory Business acquired by AstraZeneca | 575 M USD |
| 2015-12-17 | AcertaPharma | AcertaPharma acquired by AstraZeneca | 4 B USD |
| 2015-11-06 | ZS Pharma | ZS Pharma acquired by AstraZeneca | 2.7 B USD |
| 2014-07-30 | Almirall | Almirall acquired by AstraZeneca | N/A |
| 2013-06-10 | Pearl Therapeutics | Pearl Therapeutics acquired by AstraZeneca | 1.15 B USD |
| 2013-05-29 | Omthera Pharmaceuticals | Omthera Pharmaceuticals acquired by AstraZeneca | 323 M USD |
| 2012-04-23 | Ardea Biosciences | Ardea Biosciences acquired by AstraZeneca | 781 M USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-19 | Yunjian | AstraZeneca investment in Series B - Yunjian | N/A |
| 2022-08-01 | Doctor.One | AstraZeneca investment in Grant - Doctor.One | 85 K EUR |
| 2022-06-02 | Yueer Gene | AstraZeneca investment in Series B - Yueer Gene | 50 M USD |
| 2022-03-23 | Huma | AstraZeneca investment in Corporate Round - Huma | 25 M GBP |
| 2021-09-28 | Cellular Biomedicine Group | AstraZeneca investment in Series A - Cellular Biomedicine Group | 120 M USD |
| 2020-09-11 | OnDosis | AstraZeneca investment in Seed Round - OnDosis | 30 M SEK |
| 2019-06-12 | ADC Therapeutics | AstraZeneca investment in Series E - ADC Therapeutics | 76 M CHF |
| 2018-10-24 | Innate Pharma | AstraZeneca investment in Corporate Round - Innate Pharma | 62.6 M EUR |
| 2018-09-05 | PhaseBio Pharmaceuticals | AstraZeneca investment in Series D - PhaseBio Pharmaceuticals | 34 M USD |
| 2018-02-28 | Viela Bio | AstraZeneca investment in Series A - Viela Bio | 282.25 M USD |
Newest Events participated
Participated in Nordic life science Days 2017
on 2017-09-12 as sponsor
Participated in impact'17
on 2017-05-31 as sponsor
Participated in The Future of Swedish & Danish Life Science 2017
on 2017-03-30 as sponsor
Key Employee Changes
Official Site Inspections
http://www.astrazeneca.com Semrush global rank: 48.47 K Semrush visits lastest month: 2.53 M
- Host name: ac9efcde36061855b.awsglobalaccelerator.com
- IP address: 15.197.255.153
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
